# US 2003/0233377 A1 · Methods, systems, software and apparatus for prediction of polygenic conditions

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0233377 A1
- Document ID: US20030233377A1
- Status: Published application
- Kind: A1
- Application number: 10/459,933
- Filed: 2003-06-12
- Published: 2003-12-18
- Earliest claimed: 2002-06-18
- Inventors: Ilija Kovac
- Web page: https://patentgrep.com/patent/US20030233377A1

## CPC

- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 30/10: Sequence alignment; Homology search
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- Y02A 90/10: Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

The invention relates to methods, systems, software and apparatus for prediction of polygenic conditions or disorders, based on dynamical system theory. The methods of the invention include a comparison of allelic information from a test subject with that of an affected reference subject suffering from a condition or disorder, to yield a similarity measurement. The comparison may be repeated with each of a plurality of affected subjects to yield a plurality of similarity measurements. The plurality of similarity measurements is used to generate a reconstructing vector, from which a maximal similarity value is obtained, from which a probability value is derived which is used to predict whether the test subject will suffer from the condition. The invention thus provides improved genetic predictive methods which are useful in early identification of vulnerable individuals, counselling, prevention and treatment, and for the study of developmental biological complexity at the level of individual organism.

## Claims

### Claim 1

An apparatus for predicting the probability that a test subject develops a condition, said apparatus comprising:
a) an input for receiving test data containing allelic information derived from the test subject;
b) a database containing a plurality of reference data blocks, each data block containing allelic information derived from a reference subject suffering from the condition;
c) a processing unit for:
i) comparing the test data with a plurality reference data blocks to derive respective similarity measurements;
ii) deriving a predictive probability value from the similarity measurements;
d) an output to release data containing the predictive probability value.

### Claim 2 (depends on 1)

The apparatus of claim 1, wherein the allelic information comprises single nucleotide polymorphisms (SNPs).

### Claim 3 (depends on 1)

The apparatus of claim 1, wherein the allelic information is obtained from an entire genome.

### Claim 4 (depends on 1)

The apparatus of claim 1, wherein the allelic information is derived from a subset of a genome.

### Claim 5 (depends on 1)

The apparatus of claim 1, wherein said allelic information is obtained by a genotyping method based on a technique selected from the group consisting of:
a) nucleotide sequencing;
b) minisatellite marker analysis;
c) microsatellite marker analysis;
d) hybridization of allele-specific probes;
e) restriction fragment length polymorphism (RFLP) analysis; and
f) any combination of (a) to (e).

### Claim 6 (depends on 1)

The apparatus of claim 1, wherein the allelic information is obtained from a nucleic acid molecule selected from the group consisting of DNA and RNA.

### Claim 7 (depends on 6)

The apparatus of claim 6, wherein the DNA is selected from the group consisting of genomic DNA and cDNA.

### Claim 8 (depends on 1)

The apparatus of claim 1, wherein the allelic information comprises gene expression data.

### Claim 9 (depends on 1)

The apparatus of claim 1, wherein the allelic information is obtained from a source of information selected from the group consisting of:
(a) protein structure;
(b) protein function; and
(c) both (a) and (b).

### Claim 10 (depends on 1)

The apparatus of claim 1, wherein the allelic information is obtained from a part of the test subject and the reference subject.

### Claim 11 (depends on 10)

The apparatus of claim 10, wherein the part is selected from the group consisting of a tissue, cell type, and organ.

### Claim 12

A method for predicting the probability that a test subject develops a condition, said method comprising:
a) providing test data containing allelic information derived from the test subject;
b) providing a database containing a plurality of reference data blocks, each data block containing allelic information derived from a reference subject suffering from the condition;
c) comparing the test data with each reference data block to derive a plurality of respective similarity measurements; and
d) deriving a predictive probability value from the similarity measurements;
wherein the predictive probability value is used for predicting the probability that a test subject develops the condition.

### Claim 13 (depends on 12)

The method of claim 12, wherein the allelic information comprises single nucleotide polymorphisms (SNPs).

### Claim 14 (depends on 12)

The method of claim 12, wherein the allelic information is obtained from an entire genome.

### Claim 15 (depends on 12)

The method of claim 12, wherein the allelic information is derived from a subset of a genome.

### Claim 16 (depends on 12)

The method of claim 12, wherein said allelic information is obtained by a genotyping method based on a technique selected from the group consisting of:
(a) nucleotide sequencing;
(b) minisatellite marker analysis;
(c) microsatellite marker analysis;
(d) hybridization of allele-specific probes;
(e) restriction fragment length polymorphism (RFLP) analysis; and
(f) any combination of (a) to (e).

### Claim 17 (depends on 12)

The method of claim 12, wherein the allelic information is obtained from a nucleic acid molecule selected from the group consisting of DNA and RNA.

### Claim 18 (depends on 17)

The method of claim 17, wherein the DNA is selected from the group consisting of genomic DNA and cDNA.

### Claim 19 (depends on 12)

The method of claim 12, wherein the allelic information comprises gene expression data.

### Claim 20 (depends on 12)

The method of claim 12, wherein the allelic information is obtained from a source of information selected from the group consisting of:
(a) protein structure;
(b) protein function; and
(c) both (a) and (b).

### Claim 21 (depends on 12)

The method of claim 12, wherein the allelic information is obtained from a part of the test subject and the reference subject.

### Claim 22 (depends on 21)

The method of claim 21, wherein the part is selected from the group consisting of a tissue, cell type, and organ.

### Claim 23

Computer-readable media tangibly embodying a program of instructions executable by a computer to perform a method for predicting the probability that a test subject develops a condition, the method comprising:
a) providing test data containing allelic information derived from the test subject;
b) providing a database containing a plurality of reference data blocks, each data block containing allelic information derived from a reference subject suffering from the condition;
c) comparing the test data with each of a plurality of reference data block to derive a plurality of respective similarity measurements; and
d) deriving a predictive probability value from the similarity measurements;
wherein the predictive probability value is used for predicting the probability that a test subject develops the condition.

### Claim 24 (depends on 23)

The computer-readable media of claim 23, wherein the allelic information comprises single nucleotide polymorphisms (SNPs).

### Claim 25 (depends on 23)

The computer-readable media of claim 23, wherein the allelic information is obtained from an entire genome.

### Claim 26 (depends on 23)

The computer-readable media of claim 23, wherein the allelic information is derived from a subset of a genome.

### Claim 27 (depends on 23)

The computer-readable media of claim 23, wherein said allelic information is obtained by a genotyping method based on a technique selected from the group consisting of:
(a) nucleotide sequencing;
(b) minisatellite marker analysis;
(c) microsatellite marker analysis;
(d) hybridization of allele-specific probes;
(e) restriction fragment length polymorphism (RFLP) analysis; and
(f) any combination of (a) to (e).

### Claim 28 (depends on 23)

The computer-readable media of claim 23, wherein the allelic information is obtained from a nucleic acid molecule selected from the group consisting of DNA and RNA.

### Claim 29 (depends on 28)

The computer-readable media of claim 28, wherein the DNA is selected from the group consisting of genomic DNA and cDNA.

### Claim 30 (depends on 23)

The computer-readable media of claim 23, wherein the allelic information comprises gene expression data.

### Claim 31 (depends on 23)

The computer-readable media of claim 23, wherein the allelic information is obtained from a source of information selected from the group consisting of:
(a) protein structure;
(b) protein function; and
(c) both (a) and (b).

### Claim 32 (depends on 23)

The computer-readable media of claim 23, wherein the allelic information is obtained from a part of the test subject and the reference subject.

### Claim 33 (depends on 32)

The computer-readable media of claim 32, wherein the part is selected from the group consisting of a tissue, cell type, and organ.

### Claim 34

An apparatus for predicting the probability that a test subject develops a condition, said apparatus comprising:
a) an input for receiving a plurality of similarity measurements, wherein said similarity measurements are obtained by respective comparisons of a test genomic sequence from a test subject with each of a plurality of reference genomic sequences from a respective plurality of reference subjects suffering from the condition, by a comparison method comprising a physico-chemical reaction between said test and reference genomic sequences;
b) a processing unit for deriving a predictive probability value from the similarity measurements; and
c) an output to release data containing the predictive probability value.

### Claim 35 (depends on 34)

The apparatus of claim 34, wherein the comparison method is Genomic Mismatch Scanning.

### Claim 36 (depends on 34)

The apparatus of claim 34, wherein the genomic sequence is derived from an entire genome.

### Claim 37 (depends on 34)

The apparatus of claim 34, wherein the genomic sequence is derived from a subset of a genome.

### Claim 38 (depends on 34)

The apparatus of claim 34, wherein the genomic sequence is obtained from a part of the test subject and the reference subject.

### Claim 39 (depends on 38)

The apparatus of claim 38, wherein the part is selected from the group consisting of a tissue, cell type, and organ.

### Claim 40

A method for predicting the probability that a test subject develops a condition, said method comprising:
a) comparing a test genomic sequence from a test subject with each of a plurality of reference genomic sequences from a respective plurality of reference subjects suffering from the condition, by a comparison method comprising a physico-chemical reaction between said test and reference genomic sequences, to obtain a plurality of respective similarity measurements;
b) deriving a predictive probability value from the similarity measurements;
wherein the predictive probability value is used for predicting the probability that a test subject develops the condition.

### Claim 41 (depends on 40)

The method of claim 40, wherein the comparison method is Genomic Mismatch Scanning.

### Claim 42 (depends on 40)

The method of claim 40, wherein the genomic sequence is derived from an entire genome.

### Claim 43 (depends on 40)

The method of claim 40, wherein the genomic sequence is derived from a subset of a genome.

### Claim 44 (depends on 40)

The method of claim 40, wherein the genomic sequence is obtained from a part of the test subject and the reference subject.

### Claim 45 (depends on 44)

The method of claim 44, wherein the part is selected from the group consisting of a tissue, cell type, and organ.

### Claim 46

Computer-readable media tangibly embodying a program of instructions executable by a computer to perform a method for predicting the probability that a test subject develops a condition, the method comprising:
a) comparing a test genomic sequence from a test subject with each of a plurality of reference genomic sequences from a respective plurality of reference subjects suffering from the condition, by a comparison method comprising a physico-chemical reaction between said test and reference genomic sequences, to obtain a plurality of respective similarity measurements;
b) deriving a predictive probability value from the similarity measurements;
wherein the predictive probability value is used for predicting the probability that a test subject develops the condition.

### Claim 47 (depends on 46)

The computer-readable media of claim 46, wherein the comparison method is Genomic Mismatch Scanning.

### Claim 48 (depends on 46)

The computer-readable media of claim 46, wherein the genomic sequence is derived from an entire genome.

### Claim 49 (depends on 46)

The computer-readable media of claim 46, wherein the genomic sequence is derived from a subset of a genome.

### Claim 50 (depends on 46)

The computer-readable media of claim 46, wherein the genomic sequence is obtained from a part of the test subject and the reference subject.

### Claim 51 (depends on 50)

The computer-readable media of claim 50, wherein the part is selected from the group consisting of a tissue, cell type, and organ.
